PT
Perspective Therapeutics Inc.
🇺🇸XNYS.CATXUnited StatesHealthcare
$2.70USDdown -0.01 (-0.37%)ClosedDelayed8:32 PM
Price$2.70-0.01 (-0.37%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US46489V3024
- CUSIP
- 46489V302
Company
- Employees
- 163
- Headquarters
- Seattle, United States
- CEO
- Mr. Johan M. Spoor
Market
- Shares outstanding
- 114M
- Market cap
- $307.92M
Highlights
- Market cap
- $309.07M
- EPS LTM
- -$1.07
- P/E LTM
- -3.89
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $618K+80.7%up year on year
- Net income
- -$111.13M-30.48%down year on year
- Gross margin
- -489.81%-329.52%down year on year
- Free cash flow
- -$107.32M-3.47%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.